| 231 |
Sertaconazole-PLGA nanoparticles for management of ocular keratitis |
Department of Pharmaceutics |
2024 |
| 232 |
Spectral, XRD, morphological, DFT, and molecular modeling investigations of newly prepared isatin Schiff base complexes |
Department of Medicinal Chemistry |
2024 |
| 233 |
Spectrofluorimetric determination of Alogliptin benzoate through condensation with ninhydrin and phenylacetaldehyde: application to dosage form and rat plasma |
Department of Pharmaceutical Analytical Chemistry |
2024 |
| 234 |
Surface engineering of carbon microspheres with nanoceria wrapped on MWCNTs: a dual electrocatalyst for simultaneous monitoring of molnupiravir and paracetamol |
Department of Pharmaceutical Analytical Chemistry |
2024 |
| 235 |
Sustainable and efficient monitoring of tryptophan and tyrosine serum levels: a green HPTLC method as a biomarker for type 2 diabetes |
Department of Pharmaceutical Analytical Chemistry |
2024 |
| 236 |
Synergistic effects of quercetin-loaded CoFe2O4@Liposomes regulate DNA damage and apoptosis in MCF-7 cancer cells: based on biophysical magnetic hyperthermia |
Department of Industrial Pharmacy |
2024 |
| 237 |
Synthesis and characterization of new palladium (II) and silver (I) thiosemicarbazone derived by acenaphthenequinone complexes and their antimicrobial activity |
Department of Pharmaceutical Organic Chemistry |
2024 |
| 238 |
Synthesis new series of 4-pyrazolylquinolinones with apoptotic antiproliferative effects as dual EGFR/BRAFV600E inhibitors |
Department of Pharmaceutical Organic Chemistry |
2024 |
| 239 |
Synthesis, enzyme inhibition, and docking studies of new Schiff bases of disalicylic acid methylene-based derivatives as dual-target antibacterial agents |
Department of Pharmaceutical Organic Chemistry |
2024 |
| 240 |
Tetrahydro-(2H)-1,3,5-thiadiazine-2-thione (THTT), A Versatile Carrier System for Targeting Cell Cycle Checkpoint Pathways with Potential Anticancer Activities |
Department of Medicinal Chemistry |
2024 |